Viral Vitalism

Medicine

GLP-1

Consumer-friendly context on GLP-1 medications, cardiometabolic research, behavior pathways, and uncertainty.

2 published articles1 rapid brief
MedicineEarly evidenceGLP-1

GLP-1s, Dopamine, and Addiction: The Substance Use Signal

GLP-1 medications may do more than reduce appetite for food. Early clinical trials, real-world data, and preclinical research suggest they may also affect craving, reward, alcohol intake, and substance-use patterns - but the science is still developing.

16 min readRead->

News cycle

Rapid Briefs

View all ->
Drug SafetyConfirmed

The Compounded GLP-1 Boom Is Becoming a Patient-Safety and Trust Crisis

The weight-loss drug boom created a shadow market of compounded GLP-1s, fake labels, telehealth claims, dosing confusion, and patients who may not know what they are actually getting.

Why now

Regulatory warnings and investigations are converging on the same problem: patients cannot always tell what product they are receiving.

Overclaim risk
medium-high
Primary source
Investigation
Published
Jun 24, 2026
Read brief ->

Related research

STEP 1: Once-weekly semaglutide in adults with overweight or obesitySTEP 4: Effect of continued weekly semaglutide vs placebo on weight loss maintenanceSTEP 5: Two-year effects of semaglutide in adults with overweight or obesitySELECT: Semaglutide and cardiovascular outcomes in obesity without diabetesFLOW: Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes

Useful source library entries

FDA Drugs resource hubFDA approves Wegovy to reduce risk of serious heart problems in adults with obesity or overweight and cardiovascular diseaseFDA approves Zepbound as first medication for obstructive sleep apnea in adults with obesityFDA approves Wegovy for metabolic dysfunction-associated steatohepatitis with moderate-to-advanced fibrosisFDA's concerns with unapproved GLP-1 drugs used for weight loss

Related topics

MedicineRegenerative MedicineSemaglutideTirzepatideWegovyZepbound

Vital Signals

Get the weekly health signal without the wellness fog.

A clean weekly brief covering longevity science, fitness, nutrition, medicine, health culture, and the claims worth questioning.

No spam. No miracle claims. Just better health signal.

By subscribing, you agree to receive email from Viral Vitalism. Unsubscribe anytime. See our Privacy Policy.